F

aced with generic competition to big-selling drugs, Eli Lilly (LLY) plans to cut 3,500 jobs — or 8.5 percent of its global workforce – in hopes of saving $500 million annually.

Most of the cuts will occur in the U.S. through a voluntary early retirement program, although layoffs will take place as facilities are closed, such as research and development centers in Shanghai, China, and Bridgewater, N.J. Lilly currently employs about 41,000 people worldwide.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • 1) Lechleiter picked the right time to quit.

    2) Put all your eggs in the AZ basket and you see the result.

    3) Fret not, Lilyputians, you will get a great package. My wife’s severance was actually more than my salary when benefits were included. Hopefully you will get some free ducats to the Lily Corporate Center cafeteria. Best coffee in pharma.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.